research Adjuvant Scalp Rolling for Patients With Refractory Alopecia Areata
Scalp rolling might help regrow hair in people with a hair loss condition called Alopecia Areata.
Search
for
Sort by
Research
630-660 / 1000+ results research Linear Alopecia Areata in a 4-year-old Patient: A Rare Clinical Variant
A 4-year-old had a rare type of hair loss that may have a good outcome.
research Predominant expression of interleukin (IL)‐17 in chronic alopecia areata compared to IFN‐γ in pathogenic Th17 cells, tissue‐resident memory T cells and natural killer cells
IL-17 is more important than IFN-γ in causing severe hair loss in chronic alopecia areata.
research Quality of Life in Nepalese Patients with Non-Scarring Alopecia: A Cross-Sectional Observational Study at a Tertiary Center
Nepalese patients with hair loss, especially women and those with androgenetic alopecia, experience a significant decrease in quality of life.
research Effectiveness and safety of oral Janus kinase inhibitors in patients aged ≤12 with alopecia areata: a systematic review and meta-analysis
Janus kinase inhibitors can help children with alopecia areata regrow hair but may have some risks.
research THE WONDER OF HERBS TO TREAT–ALOPECIA
Herbs like aloe vera and amla are effective and safe for treating hair loss.
research Formulation and evaluation of dry herbal powder shampoo
The dry herbal powder shampoo showed promise but needs more work to enhance quality and safety.
research Promotion of Skin Carcinogenesis by Dimethylarsinic Acid in Keratin (K6)/ODC Transgenic Mice
Dimethylarsinic acid speeds up skin tumor growth in certain mice.
research A case of refractory alopecia areata successfully treated by combining delgocitinib ointment with excimer laser
Combining delgocitinib ointment with excimer laser can effectively treat severe alopecia areata.
research 93 Approach to Managing Recalcitrant Alopecia Areata With Combination Therapy: A Series of Five Cases in Black Pediatric Patients
Combination therapy, including JAK inhibitors, effectively regrows hair and reduces severity in Black children with stubborn Alopecia Areata.
research El papel de los inhibidores de JAK en la alopecia areata: revisión de la literatura
JAK inhibitors help treat alopecia areata but have high recurrence after stopping.
research Epidemiological pattern of dermatophytosis in calves from Tarai region of Uttarakhand, India
Dermatophytosis in calves is most common in winter, especially in 4-6 month-old female HF crossbreds.
research Evaluation of Eclipta alba L. selections for higher biomass and bioactive compound
Eclipta alba IIHR Sel EA 43 is best for large-scale cultivation due to high growth, yield, and wedelolactone content.
research JAK-inhibitors. New players in the field of immune-mediated diseases, beyond rheumatoid arthritis
JAK inhibitors are effective in treating various immune-related diseases, not just rheumatoid arthritis.
research Why You Should Choose Hair Restoration In Bangalore
research Comparative study between fractional carbon dioxide laser vs intralesional steroid injection in treatment of alopecia areata
FCO2 laser is a better treatment for alopecia areata than intralesional steroids.
research Pulse cyclophospamide in severe lupus nephritis: Southern Indian experience.
IV cyclophosphamide effectively treated severe lupus nephritis in Indian patients.
research Formulation And Evaluation Of Herbal Hair Dye Using Platycladus Orientalis For Preventing Hair Loss”
The herbal hair dye using Platycladus orientalis effectively prevents hair loss, covers gray, and is gentle and safe for all ages.
research Identification of Loliolide with Anti-Aging Properties from Scenedesmus deserticola JD052
Loliolide from Scenedesmus deserticola may help with anti-aging.
research Upadacitinib in dermatologic therapy: Emerging evidence and expanding indications
Upadacitinib effectively treats skin conditions like eczema and psoriasis and is becoming more widely used and affordable.
research Under Development JAK Inhibitors for Dermatologic Diseases
New JAK inhibitor drugs show promise for treating skin diseases but need more research on safety and effectiveness.
research Topical Janus kinase inhibitors: A review of applications in dermatology
Topical JAK inhibitors may help treat some skin conditions but need more research.
research Review on Semecarpus Anacardium Linn
Semecarpus anacardium Linn. is a plant with many health benefits, including reducing inflammation, fighting cancer, and stimulating hair growth.
research PREPARATION OF ANTI-DANDRUFF SHAMPOO FROM POLY HERBAL FORMULATION AND ITS ANTIOXIDANT, ANTIMICROBIAL AND ANTIINFLAMMATORY ACTIVITY OF AQUEOUS EXTRACT OF DIFFERENT PARTS OF AZADIRACHTA INDICA, OCIMUM TENUIFLORUM, ECLIPTA PROSTRATA, PHYLLANTHUS EMBLICA, HIBISCUS ROSA-SINENSIS, AND SAPINDUS MUKOROSSI-A NOVEL APPROACH
The herbal shampoo effectively treats dandruff and is a good alternative to synthetic options.
research 15thJornada de DermatologÃa of the Faculty of Medicine, ClÃnica Alemana â University of Desarrollo, Santiago, Chile, October 22-24, 2009
The 15th Jornada de Dermatología was a successful dermatology event with international experts discussing various topics.
research LUPUS VASCULITIS
A woman with Lupus Vasculitis improved after treatment with steroids and other medications.
research JAK Inhibitor Therapy in Alopecia Areata with Latent Hepatitis B Virus or Tuberculosis Infection: A Safety Assessment
JAK inhibitors can be safely used for alopecia areata in patients with latent hepatitis B or stable tuberculosis with proper monitoring.
research BJP volume 171 issue 6 Cover and Back matter
research Uso de las especies medicinales como productos forestales no maderables en el sitio la Tranca Arriba, parroquia San Plácido
Medicinal plants are important for local health in La Tranca Arriba.
research Open-Label, Randomized, Multicenter, Phase III Study Comparing Oral Paclitaxel Plus Encequidar Versus Intravenous Paclitaxel in Patients With Metastatic Breast Cancer
Oral paclitaxel plus encequidar improved tumor response and caused less neuropathy but more serious infections than intravenous paclitaxel.